Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2011 Dec 1.

Published in final edited form as: Bipolar Disord. 2010 Dec;12(8):825–833. doi: 10.1111/j.1399-5618.2010.00884.x

Table 2.

Post-hoc analysis for the metabolites of phosphomonoesters (PME), phosphoethanolamine (PEtn), and phosphocholine (PCho) at each treatment level

Metabolites	Uridine versus baseline			Placebo versus baseline
Metabolites	Coef^a	z	p-value^b	Coef^a	z	p-value^b
PME	0.512	4.31	< 0.001^c	−0.317	−1.80	0.07
PEtn	0.378	4.29	< 0.001^c	−0.203	−1.70	0.09
PCho	0.147	0.92	0.35	−0.100	−0.33	0.74

^a

Coefficient values represent percentage change of metabolite levels versus total phosphorus over time (between baseline and treatment).

^b

Sidak corrected.

^c

Statistical significance (generalized estimating equation analysis, p < 0.05)